<?xml version="1.0" encoding="UTF-8"?>
<list list-type="simple">
 <list-item>
  <label>1.</label>
  <p>required nearly full assistance in their daily lives or were incapable of walking and standing,</p>
 </list-item>
 <list-item>
  <label>2.</label>
  <p>taking azathioprine, mercaptopurine hydrate, vidarabine, or didanosine,</p>
 </list-item>
 <list-item>
  <label>3.</label>
  <p>serum creatinine exceeded 1.5 times the upper limit of the reference value or patients whose AST (GOT) or ALT (GPT) exceeded 2 times the upper limit of the reference value in the test before the registration,</p>
 </list-item>
 <list-item>
  <label>4.</label>
  <p>underwent surgical treatment for PD,</p>
 </list-item>
 <list-item>
  <label>5.</label>
  <p>history or present illness of gout, hyperuricemia, or urolithiasis,</p>
 </list-item>
 <list-item>
  <label>6.</label>
  <p>past or current treatment with febuxostat,</p>
 </list-item>
 <list-item>
  <label>7.</label>
  <p>history of hypersensitivity/idiosyncrasy (allergy) to any drug or drugs (not limited to the study drugs),</p>
 </list-item>
 <list-item>
  <label>8.</label>
  <p>used an investigational drug within 30 days of signing the consent form,</p>
 </list-item>
 <list-item>
  <label>9.</label>
  <p>pregnant, possibility of pregnancy or lactating, or</p>
 </list-item>
 <list-item>
  <label>10.</label>
  <p>judged inappropriate for other reasons by the investigator or sub-investigator.</p>
 </list-item>
</list>
